AKT1 and hepatocellular carcinoma: As expected, AKT inhibitors significantly increased the intracellular levels of MDA and iron and reduced the GSH/GSSG ratio (Figure 4I; Figure S4J,L, Supporting Information), while AKT activators reversed the alteration of these ferroptosis indicators in shPGAM1 HCC cells.